See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.48▲ 1.58%
← 0Q19 page
XStocksXray
Market X-Ray report · 27 October 2026

CEVA Inc. (0Q19)

London Stock Exchange · UK · prices in USD · close of 27 Oct 2026

Key indicators

Last closeUSD 31.34
52-week range17.16 – 52.00
Return, 1 month / 3 months−13.6% / −8.9%
Return, 1 year / 3 years+11.5% / +83.1%
TrendUptrend
RSI (14)51
Volatility (1 year)74.7%
Worst drawdown (1 year)-49.1%
Average daily value traded0.10M USD
Dividend yield–

Market X-Ray price-based

37/ 100 · High confidence · ahead of 27% of stocks on this exchange
Trend39
Momentum60
Stability (higher is calmer)16
Liquidity30
Income–

Five-year price chart navy: price · brown: 200-day average

14.3224.0333.7543.4753.182021-102024-062025-052026-012026-10

About the company

CEVA Inc. licenses signal processing technology and related intellectual property to semiconductor and electronics companies. Its products include digital signal processor cores, wireless connectivity platforms, and software for audio, vision, and sensor applications. Customers use this technology in chips for smartphones, consumer devices, automotive systems, and the internet of things. The company is based in the United States and works with chip designers and manufacturers around the world.

CEVA Inc. trades under the code 0Q19 on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

CEVA Inc. (0Q19) trades on the London Stock Exchange in UK. It last closed at USD 31.34 on 27 October 2026.

Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,769 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 11.5% and over the last three months it fell 8.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
CEVA Inc. (0Q19)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend39 · WeakBelow its long-term averages and far from its highs.
Above 200-day average2.1%
From 52-week high-38.7%
Momentum60 · FairTypical recent returns for this exchange.
3-month return-8.9%
6-month return15.1%
12-month return, skipping the last month29.0%
Stability (higher is calmer)16 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)74.7%
Worst drawdown, 1 year (smaller is calmer)-49.1%
Liquidity30 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.10M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+8.7%
1 month−13.6%
3 months−8.9%
6 months+15.1%
1 year+11.5%
3 years+83.1%
5 years−30.0%

Signals

50-day / 200-day average30.31 / 30.70
Golden / death cross (60 days)Death, 5 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.88

Technical summary

DailyNeutral6 bullish · 4 neutral · 6 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026